Evidence map›Paper›PMID 9927649›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1999

Niemann-Pick C1 protein: obligatory roles for N-terminal domains and lysosomal targeting in cholesterol mobilization.

H Watari, E J Blanchette-Mackie, N K Dwyer, J M Glick, S Patel, E B Neufeld, R O Brady, P G Pentchev, J F Strauss

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
9.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 163 citations in OpenAlex.

  1. Efficacy and safety of efavirenz in Niemann-Pick disease type C.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

H WatariCenter for Research on Reproduction and Women's Health, Departments of Obstetrics and Gynecology, University of Pennsylvania Medical Center, Philadelphia, PA 19104, USA.
E J Blanchette-Mackie
N K Dwyer
J M Glick
S Patel
E B Neufeld
R O Brady
P G Pentchev
J F Strauss
National Institute of Diabetes and Digestive and Kidney Diseases · US

Funding

REPRODUCTIVE BIOLOGYP01HD006274 · NICHD · UNIVERSITY OF PENNSYLVANIA · PI GERTON, GEORGE L. · 1985 to 2006
$8.7M
ULTRASTRUCTURAL IMMUNOCYTOCHEMISTRY OF LIPID METABOLISM IN CELLS AND TISSUEZ01DK060003 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI BLANCHETTE-MACKIE, E. JOAN · 1995 to 2008
$610k
CHOLESTEROL AND NEURODEGENERATIONR01NS034339 · NINDS · NEW ENGLAND BIOMEDICAL RESEARCH CENTER · PI PATEL, SHUTISH C. · 1995 to 2001
$398k
NICHD NIH HHS HD06274NICHD NIH HHS P01 HD006274NINDS NIH HHS NS34339
6 · The paper itself

Abstract

Niemann-Pick type C (NPC) disease is an inherited lipid storage disorder that affects the viscera and central nervous system. A characteristic feature of NPC cells is the lysosomal accumulation of low density lipoprotein-derived cholesterol. To elucidate important structural features of the recently identified NPC1 gene product defective in NPC disease, we examined the ability of wild-type NPC1 and NPC1 mutants to correct the excessive lysosomal storage of low density lipoprotein-derived cholesterol in a model cell line displaying the NPC cholesterol-trafficking defect (CT60 Chinese hamster ovary cells). CT60 cells transfected with human wild-type NPC1 contained immunoreactive proteins of 170 and 190 kDa localized to the lysosomal/endosomal compartment. Wild-type NPC1 protein corrected the NPC cholesterol-trafficking defect in the CT60 cells. Mutation of conserved cysteine residues in the NPC1 N terminus to serine residues resulted in proteins targeted to lysosomal membranes encircling cholesterol-laden cores, whereas deletion of the C-terminal 4-aa residues containing the LLNF lysosome-targeting motif resulted in the expression of protein localized to the endoplasmic reticulum. None of these mutant NPC1 proteins corrected the NPC cholesterol-trafficking defect in CT60 cells. We conclude that transport of the NPC1 protein to the cholesterol-laden lysosomal compartment is essential for expression of its biological activity and that domains in the N terminus of the NPC1 protein are critical for mobilization of cholesterol from lysosomes.

Indexed as

Carrier ProteinsMembrane GlycoproteinsAmino Acid SubstitutionAnimalsCHO CellsCholesterolCricetinaeEndoplasmic ReticulumFilipinGreen Fluorescent ProteinsHumansIntracellular Signaling Peptides and ProteinsLuminescent ProteinsLysosomesMutagenesis, Site-DirectedNiemann-Pick C1 ProteinCarrier ProteinsCholesterolFilipinGreen Fluorescent ProteinsIntracellular Signaling Peptides and ProteinsLuminescent ProteinsMembrane GlycoproteinsNiemann-Pick C1 ProteinNPC1 protein, humanProteinsRecombinant Proteins

Identifiers

PMID9927649
PMCPMC15306
OpenAlexW2026324678

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.